The demographics (DM) domain is used to represent information about the participants in a clinical study. Note there are 4 participants in this DM dataset while the following example datasets only show 1test results are only shown for1 participant.
| Dataset wrap |
|---|
|
| Dataset2 |
|---|
| Row | STUDYID | DOMAIN | USUBJID | SUBJID | RFSTDTC | RFENDTC | RFXSTDTC | RFXENDTC | RFICDTC | RFPENDTC | DTHDTC | DTHFL | SITEID | BRTHDTC | AGE | AGEU | SEX | RACE | ARMCD | ARM | ACTARMCD | ACTARM | ARMNRS | ACTARMUD | COUNTRY |
|---|
| 1 | DMD-EF | DM | DMD-EF-01-101 | 101 | 2022-05-16T09:00 |
|
|
| 2022-05-16 |
|
|
| 01 | 2010-02-07 | 12 | YEARS | M | BLACK OR AFRICAN AMERICAN | A | Drug A | A | Drug A |
|
| USA | | 2 | DMD-EF | DM | DMD-EF-01-102 | 102 | 2022-06-13T08:00 |
|
|
| 2022-06-13 |
|
|
| 01 | 2008-05-01 | 14 | YEARS | M | ASIAN | A | Drug A | A | Drug A |
|
| MYS | | 3 | DMD-EF | DM | DMD-EF-01-103 | 103 | 2022-07-15T10:15 |
|
|
| 2022-07-15 |
|
|
| 01 | 2003-07-10 | 19 | YEARS | M | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | B | Drug B | B | Drug B |
|
| BRA | | 4 | DMD-EF | DM | DMD-EF-01-104 | 104 | 2022-09-06T09:30 |
|
|
| 2022-09-06 |
| 2023-11-23 | Y | 01 | 1999-01-15 | 23 | YEARS | M | WHITE | B | Drug B | B | Drug B |
|
| IRL |
|
|
...
| Dataset wrap |
|---|
|
| Rowcaps |
|---|
| Rows 1-8: | Show the baseline CMR ejection fraction measurements for the participant at visit 1. | | Rows 9-16: | Show the CMR ejection fraction measurements for the participant at visit 6. |
|
| Dataset2 |
|---|
| | Row | STUDYID | DOMAIN | USUBJID | CVSEQ | CVLNKID | CVTESTCD | CVTEST | CVORRES | CVORRESU | CVSTRESC | CVSTRESN | CVSTRESU | CVLOC | CVMETHOD | CVLOBXFL | VISITNUM | VISIT | CVDTC | CVDY |
|---|
| 1 | DMD-EF | CV | DMD-EF-01-101 | 1 |
| ESV | End Systolic Volume | 32 | mL | 32 | 32 | mL | HEART, LEFT VENTRICLE | MRI |
| 1 | VISIT 1 | 2022-05-16 | 1 | | 2 | DMD-EF | CV | DMD-EF-01-101 | 2 |
| EDV | End Diastolic Volume | 95 | mL | 95 | 95 | mL | HEART, LEFT VENTRICLE | | | 1 | VISIT 1 | 2022-05-16 | 1 | | 3 | DMD-EF | CV | DMD-EF-01-101 | 3 | 2 | LVEF_C | Left Ventricular Ejection Fraction, Cal | 70 | % | 70 | 70 | % | HEART, LEFT VENTRICLE | MRI |
| 1 | VISIT 1 | 2022-05-16 | 1 | | 4 | DMD-EF | CV | DMD-EF-01-101 | 4 | 2 | CARDOUT | Cardiac Output | 5.4 | L/min | 5.4 | 5.4 | L/min | HEART, LEFT VENTRICLE | | | 1 | VISIT 1 | 2022-05-16 | 1 | | 5 | DMD-EF | CV | DMD-EF-01-101 | 5 |
| ESV | End Systolic Volume | 24 | mL | 24 | 24 | mL | HEART, RIGHT VENTRICLE | | | 1 | VISIT 1 | 2022-05-16 | 1 | | 6 | DMD-EF | CV | DMD-EF-01-101 | 6 |
| EDV | End Diastolic Volume | 90 | mL | 90 | 90 | mL | HEART, RIGHT VENTRICLE | MRI |
| 1 | VISIT 1 | 2022-05-16 | 1 | | 7 | DMD-EF | CV | DMD-EF-01-101 | 7 | 2 | RVEF_C | Right Ventricular Ejection Fraction, Cal | 75 | % | 75 | 75 | % | HEART, RIGHT VENTRICLE | | | 1 | VISIT 1 | 2022-05-16 | 1 | | 8 | DMD-EF | CV | DMD-EF-01-101 | 8 | 2 | CARDOUT | Cardiac Output | 5.6 | L/min | 5.6 | 5.6 | L/min | HEART, RIGHT VENTRICLE | | | 1 | VISIT 1 | 2022-05-16 | 1 | | 9 | DMD-EF | CV | DMD-EF-01-101 | 9 |
| ESV | End Systolic Volume | 37 | mL | 37 | 37 | mL | HEART, LEFT VENTRICLE | MRI |
| 6 | VISIT 6 | 2023-04-06 | 325326 | | 10 | DMD-EF | CV | DMD-EF-01-101 | 10 |
| EDV | End Diastolic Volume | 94 | mL | 94 | 94 | mL | HEART, LEFT VENTRICLE | | | 6 | VISIT 6 | 2023-04-06 | 325326 | | 11 | DMD-EF | CV | DMD-EF-01-101 | 11 | 2 | LVEF_C | Left Ventricular Ejection Fraction, Cal | 65 | % | 65 | 65 | % | HEART, LEFT VENTRICLE | MRI |
| 6 | VISIT 6 | 2023-04-06 | 325326 | | 12 | DMD-EF | CV | DMD-EF-01-101 | 12 | 2 | CARDOUT | Cardiac Output | 4.0 | L/min | 4.0 | 4.0 | L/min | HEART, LEFT VENTRICLE | | | 6 | VISIT 6 | 2023-04-06 | 325326 | | 13 | DMD-EF | CV | DMD-EF-01-101 | 13 |
| ESV | End Systolic Volume | 36 | mL | 36 | 36 | mL | HEART, RIGHT VENTRICLE | | | 6 | VISIT 6 | 2023-04-06 | 325326 | | 14 | DMD-EF | CV | DMD-EF-01-101 | 14 |
| EDV | End Diastolic Volume | 93 | mL | 93 | 93 | mL | HEART, RIGHT VENTRICLE | MRI |
| 6 | VISIT 6 | 2023-04-06 | 325326 | | 15 | DMD-EF | CV | DMD-EF-01-101 | 15 | 2 | RVEF_C | Right Ventricular Ejection Fraction, Cal | 70 | % | 70 | 70 | % | HEART, RIGHT VENTRICLE | | | 6 | VISIT 6 | 2023-04-06 | 325326 | | 16 | DMD-EF | CV | DMD-EF-01-101 | 16 | 2 | CARDOUT | Cardiac Output | 4.0 | L/min | 4.0 | 4.0 | L/min | HEART, RIGHT VENTRICLE | | | 6 | VISIT 6 | 2023-04-06 | 325326 |
|
|
The lab test, N-Terminal ProB-type Natriuretic Peptide, is a biomarker used in heart failure and ejection fraction for diagnosis and treatment (ref: https://pubmed.ncbi.nlm.nih.gov/34918487/; ref: https://pubmed.ncbi.nlm.nih.gov/33039447/). These test results are represented in the laboratory test results (LB) domain.
| Dataset wrap |
|---|
|
| Rowcaps |
|---|
| Row 1: | Shows the results for the N-Terminal ProB-type Natriuretic Peptide test at visit 1. | | Row 2: | Shows the results for the N-Terminal ProB-type Natriuretic Peptide test at visit 6. |
|
| Dataset2 |
|---|
| Row | STUDYID | DOMAIN | USUBJID | LBSEQ | LBLNKID | LBTESTCD | LBTEST | LBCAT | LBORRES | LBORRESU | LBORNRLO | LBORNRHI | LBSTRESC | LBSTRESN | LBSTRESU | LBSTNRLO | LBSTRNHI | LBNRIND | LBLOINC | LBSPEC | LBLOBXFL | VISITNUM | VISIT | LBDTC | LBDY |
|---|
| 1 | DMD-EF | LB | DMD-EF-01-101 | 1 | 2 | BNPPRONT | N-Terminal ProB-type Natriuretic Peptide | CHEMISTRY | 40 | pg/mL | 0 | 100 | 40 | 40 | IU/L | 100 | 40 | NORMAL | 71425-3 | BLOOD |
| 1 | VISIT 1 | 2022-05-16 | 1 | | 2 | DMD-EF | LB | DMD-EF-01-101 | 2 | 2 | BNPPRONT | N-Terminal ProB-type Natriuretic Peptide | CHEMISTRY | 900 | pg/mL | 0 | 100 | 900 | 900 | IU/L | 100 | 900 | HIGH | 71425-3 | BLOOD |
| 6 | VISIT 6 | 2023-04-06 | 325326 |
|
|
A related records (RELREC) dataset is used to show the relationship between the CV and LB domains.
...